Earnings Releases·Nov 4, 2026, 6:46 AM ET

Versigent — Third Quarter 2026 Earnings Summary

Net sales rose 7.2% year-over-year to $2,450 million, while adjusted net sales growth was approximately 1%; however, net income declined to $102 million from $109 million in the prior-year quarter due to $36 million in interest expense and higher capital expenditures.
Adjusted EBITDA increased 10.9% year-over-year to $275 million with an 11.2% margin (up 40 basis points), and Free Cash Flow decreased to $170 million from $179 million primarily due to elevated capital spending.
Management raised full-year 2026 net sales guidance midpoint to $9,500 million (range $9,500–$9,600 million), tightened Adjusted EBITDA guidance to $970–$1,010 million, and increased Free Cash Flow guidance to $275–$325 million.
The company secured $2.1 billion in bookings and declared a quarterly cash dividend of $0.13 per share, while long-term debt increased to $2,066 million following Q1 2026 financing.